Abstract
Primary pulmonary amyloidosis is a relatively rare condition, characterized by amyloid deposition in the lungs and other associated structures. We report a case of primary nodular parenchymal pulmonary amyloidosis in a 44-year-old male. The patient was referred to our hospital for further evaluation of multiple lobulated nodules in both lungs. As the multiple lung nodules were suspected to be metastatic, 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) was conducted, which revealed that the nodules had a mild uptake of 18F-FCG. Amyloidosis was confirmed by conducting a percutaneous CT-guided fine-needle aspiration (FNA) biopsy in the left lung nodule. A literature review of previous studies on primary nodular parenchymal pulmonary amyloidosis from Medline (1970-October 2011) and Embase (1989-October 2011) was also included. Despite its rarity, primary nodular parenchymal pulmonary amyloidosis with a pattern of multiple nodules also forms part of the differential diagnosis of pulmonary metastases with high 18F-FDG uptake on PET/CT.
Keywords: amyloidosis, pulmonary nodules, metastases
Introduction
Amyloidosis is a clinical disorder caused by extracellular deposition of insoluble abnormal fibrils in various organs and is derived from the aggregation of misfolded, normally soluble, proteins (1). Primary pulmonary amyloidosis is a relatively rare pattern of amyloidosis that is confined to the lungs and associated structures without any other organ involvement. It occurs in 3 patterns: tracheobronchial, diffuse interstitial and nodular parenchymal (2). Radiographically, the lesions of primary nodular parenchymal pulmonary amyloidosis may be single or multiple, and are able to calcify or cavitate. It is usually considered in the differential diagnosis of pulmonary primary or metastatic neoplasms. In the present study, we report a case of primary nodular parenchymal pulmonary amyloidosis and review the literature for related cases in Medline (1970-October 2011) and Embase (1989-October 2011).
Patient and methods
Case report
A 44-year-old male was referred to our hospital for further evaluation of multiple lobulated nodules of varying sizes in both lungs that were detected on a chest computed tomography (CT) scan conducted in a health examination 1 week earlier. The patient’s medical history included an appendectomy that was conducted 10 years previously. Additionally, the patient was a non-smoker and did not suffer from pulmonary or systemic symptoms. Physical examinations and laboratory findings, including analysis of tumour markers, were all of no significance. As metastases was suspected in the multiple lung nodules, 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) /CT was conducted to characterize the nodules and to detect a possible primary malignancy. The 18F-FDG PET/CT revealed that the nodules had a mild uptake of 18F-FDG suggestive of malignancy, with a maximum standardized uptake value (SUVmax) of 1.19 (Fig. 1). Other than these pulmonary nodules, there was no evidence of a high-uptake lesion indicative of a primary malignancy anywhere else in the body. A percutaneous CT-guided fine-needle aspiration (FNA) biopsy was conducted in the left lung nodule. Histologically, the specimens contained amorphous, homogeneous material with a few lymphocytes. Congo red staining was positive (Fig. 2), which confirmed the deposition of amyloid within the specimen. Therefore, we established a diagnosis of primary nodular parenchymal pulmonary amyloidosis and discharged the patient without chemotherapy. The patient enjoys good clinical condition 1 year later.
Figure 1.
18F-FDG PET/CT of the present case showing multiple lung nodules with mild 18F-FDG uptake and a SUVmax of 1.19 for a nodule in the right lower lobe (arrow). 18F-FDG PET/CT, 18F-fluorodeoxyglucose positron emission tomography/computed tomography; SUV, standardized uptake value.
Figure 2.
Histology of the present case showing the deposition of amyloid within the nodule. (left, H&E staining; right, Congo red staining; magnification, x100). H&E, hematoxylin and eosin.
Methods
We searched for previous cases of primary nodular parenchymal pulmonary amyloidosis in Medline (1970-October 2011) and Embase (1989-October 2011), using a search strategy combining medical subject headings and the key words ‘lung’ and ‘amyloidosis’.
Results
We identified 19 articles (3–21) describing primary nodular parenchymal pulmonary amyloidosis in Medline and Embase. Data on clinical presentation, radiographic pattern, biopsy and survival of 58 patients (including our case) are summarized in Table I. Ages ranged from 44 to 89 years and, consistent with previous findings, the average age of the patients was in the sixth decade (9,12,16). There were 8 male and 12 female cases, while the gender was not indicated in 38 cases. The patients were usually asymptomatic, and the amyloidosis was discovered accidentally on routine chest radiography. Few of these cases were associated with cough or hemoptysis. Radiologically, the nodular parenchymal pattern appeared as solitary or multinodular infiltrates in any lobe, usually mimicking neoplastic growth. Nodules ranged in diameter from 1 to 4 cm, with 15 cm being the largest nodule reported in the literature (22). Biopsy data were available for 22 patients. Of these 22 patients, nodule resection was conducted in 9, lobectomy was conducted in 8, and percutaneous FNA biopsy was conducted in 5. Patients with a nodular parenchymal pattern were all in good condition during follow-up.
Table I.
Cases of primary nodular parenchymal pulmonary amyloidosis.
| Author/Year, (Ref.) | Age (years)/ gender | Clinical presentation | Radiographic pattern | Biopsy (pathology) | Survival |
|---|---|---|---|---|---|
| Chaudhuri and Parker, 1970 (3) | 66/M | Asymptomatic | Smooth, round shadow in the lateral basal segment of the right lower lung lobe (CXR) | Right lower lobectomy (a round nodule 2.5 cm in diameter, in the lateral basal segment of the right lower lobe) | Patient was well postoperatively |
| Moldow, et al, 1972 (4) | 58/F | Six month history of cough | Infiltrative lesions involving both upperlung lobes (CXR) | Thoracotomy, a wedge resection of an accessible nodule in the left lower lobe (the left upper lobe was studded with numerous form to hard 1–3 cm nodules) | Chest roentgenogram remained unchanged 1 year later |
| Dyke, et al, 1974 (5) | 51/M | Chronic cough | Well-circumscribed opacity in the periphery of the left upper lung lobe (CXR) | Thoracotomy, an subpleural nodule (1.5 cm in diameter) of the anterior segment of the left upper lobe was excised | Patient was well until the age of 60 years |
| Brauner, et al, (6) 1974 | 70/F | Chronic cough | 2.5 cm soft tissue lesion in the upper lobe of the left lung (CXR) | A wedge resection of the lesion in the left lung | ND |
| Bonfils-Roberts, et al, 1975 (7) | 55/F | Asymptomatic | Lobulated left parahilar mass (4 cm in diamter) (CXR) | Thoracotomy, a left lower lobectomy | Postoperative recovery was satisfactory |
| Makinen, et al, 1977 (8) | 67/F | Asymptomatic | Tumour-like infiltration in the lower lobe of the right lung (CXR) | Thoracotomy, the mass was excised (approximately 3 cm in diameter) | ND |
| Rubinow, et al, 1978 (9) | 63/M | Asymptomatic | Mass lesion in the left upper lung lobe (CXR) | Left upper lobectomy | Lost in follow-up and died in an automobile accident 3 years later |
| Desai, et al, 1979 (10) | i) 69/M; | i) Chronic cough | i) 2 nodular opacities in the lower half of left lung | i) Transcutaneous biopsy with a needle under uoroscopic guidance | i) ND |
| ii) 48/F | ii) Aymptomatic | ii) Bilateral pulmonary nodules (CXR) | ii) Open biopsy of the lung (a nodule was resected) | ii) ND | |
| Schoen, et al, 1980 (11) | 64/M | A chronic cough productive of white sputum | A chest roentgenogram showed a peripheral 4x2-cm noncalcified pleural-based mass with irregular borders in the left lateral mid-lung field (CXR) | Wedge resection of 2 nodules in the left upper lobe (4.0×3.5×1.0 cm and 1.8×0.8×0.6 cm) | ND |
| Hui, et al, 1986 (12) | Mean, 64 (28 cases) | Asymptomatic | Nodular lesions were circumscribed, showed no evidence of calcification, and ranged in size from 1 to 4 cm (CXR) | ND | ND |
| Kamei, et al, 1989 (13) | 77/M | Asymptomatic | Multiple nodular shadows in both lungs (2 vessel like shadows connected to 1 nodular lesion in the right lower lobe) (CXR) | Right lower lobectomy | Patient was well with no special treatment following surgery |
| Davis, et al, 1991 (14) | 56/M | Pleuritic pain; hemoptysis | Left hilar mass and bilateral dense nodules in the pulmonary parenchyma (CT) | Thoracotomy; the mass was resected and wedge resections were performed on 2 nodules from the left upper lobe (those >1.5 cm in diameter) | Uneventful recovery |
| Mollers, et al, 1992 (15) | 88/F | A single episode of hemoptysis | 3 partially calcified nodules in both lower lung (CXR) | Transthoracic coaxial fine needle | Good condition and asymptomatic 20 months later |
| Utz, et al, 1996 (16) | Mean, 67 (7 cases) | NA | Single nodule (5 patients); multiple nodules (2 patients) (ND) | Biopsy (described unclearly) | ND |
| Khoor, et al, 2004 (17) | i) 62/F | i) Episode of severe exacerbation of asthma | i) Multiple, bilateral pulmonary nodules; | i) Thoracotomy (right middle-lobe biopsy) and a video assisted thoracoscopic wedge biopsy 9 months later (>5.0 cm) | i) Pulmonary nodules were stable 1 year later |
| ii) 65/F | ii) Asymptomatic | ii) Solitary pulmonary nodule in the right upper lobe | ii) Right upper lobectomy (2.4 cm) | ii) ND | |
| iii) 69/F | iii) Asymptomatic | iii) Solitary pulmonary nodule in the left upper lobe (radiological method was not mentioned) | iii) Left upper lobectomy (>4.0 cm) | iii) ND | |
| Biewend, et al, 2006 (18) | i) 75 | NA | NA | NA | i) No disease |
| ii) 73 | NA | NA | NA | ii) Stable disease | |
| iii) 65 | NA | NA | NA | iii) ND | |
| Adžić, et al, 2008 (19) | 52/F | Hemoptysis for 1 year | Nodular, multiple, bilateral soft tissue densities (HRCT) | Open lung biopsy (the nodules measured >3 cm) | Good clinical condition 3 years later |
| Yang, et al, 2009 (20) | 58/F | Asymptomatic | Multiple lung nodules (CT) | CT guided percutaneous FNA biopsy of 1 nodule | ND |
| Seo, et al, 2010 (21) | 54/F | Asymptomatic | Multiple nodules (>2.5 cm) in both lungs (CT); mild FDG uptake in the pulmonary nodules (SUVmax 1.8) (PET/CT) | Open lung wedge resection of the right pulmonary nodules | ND |
| Present case | 44/M | Asymptomatic | Multiple lobulated nodules of varying sizes in both lungs (CT); mild FDG uptake in the pulmonary nodules (SUVmax 1.19) (PET/CT) | Percutaneous CT-guided core biopsy was obtained from the left lung nodule | Patient enjoys good clinical condition 1 year later |
M, male; F, female; CXR, chest radiography; CT, computed tomography; NA, not available; ND, not described; FDG, fluorodeoxyglucose; FNA, fine-needle aspiration; SUV, standardized uptake value; PET, positron emission tomography.
Discussion
Amyloidosis is a disease caused by extracellular amyloid deposits (23). Amyloid fibres are formed by the folding of various fibril precursor proteins into an alternative conformation rich in β-sheet structures. This characteristic structure results in specific staining with Congo red dye that yields an apple-green birefringence under polarized light microscopy. The genetic and/or environmental factors in individual susceptibility to amyloid deposition have not been elucidated (22). Primary pulmonary amyloidosis is characterized by amyloid deposition in the lungs and other associated structures. Radiologically, the primary nodular parenchymal pulmonary amyloidosis appear as single or multiple nodules in any lobe, and should be considered in the differential diagnosis of pulmonary primary or metastatic neoplasms. In our study, there is no specific examination for the preoperative diagnosis of primary nodular parenchymal pulmonary amyloidosis without the presence of classic clinical findings, laboratory tests and radiological results. The final diagnosis usually requires histological confirmation.
The optimal technique for biopsy is uncertain. In our study, open lung biopsy was the most commonly used method for obtaining biopsy material, but it was more invasive than CT-guided percutaneous FNA biopsy. It is worth noting that CT-guided percutaneous FNA biopsy has also been used when a less invasive approach is necessary and 5 cases of our study were diagnosed solely on the basis of material obtained by percutaneous FNA biopsy, avoiding unnecessary invasive surgical resection. Once the diagnosis is clear, nodular parenchymal amyloidosis rarely requires treatment, which may involve surgical resection if a large nodule causes a space-occupying effect. Additionally, the majority of patients with a nodular parenchymal pattern were in good condition during follow-up.
18F-FDG PET/CT is most widely used for cancer detection by revealing which tissues have a high metabolic rate and take up greater amounts of glucose in comparison to the surrounding tissues. To a certain extent, the high metabolic rate usually correlates with more aggressive tumors and a greater number of viable tumor cells (24). The use of 18F-FDG PET/CT for the diagnostic workup of pulmonary nodules to reduce inappropriate invasive diagnostic investigation and subsequent complications is emerging. Duhaylongsod et al (25) reported that the SUV of 18F-FDG uptake in malignant nodules (SUV≥2.5) was greater than benign pulmonary nodules; the sensitivity, specificity and accuracy were 97, 82 and 92%, respectively. However, 18F-FDG is known to have little uptake in malignancies with low metabolic activity, including bronchoalveolar cancer, carcinoid tumor and mucinous adenocarcinoma. Furthermore, certain noncancerous conditions may also demonstrate high metabolic rates (26). Increased 18F-FDG activity has been demonstrated in cases of tuberculosis, sarcoidosis, fungal disease, interstitial lung disease, osteoarthritis, vascular thromboses, osteoporosis and rheumatoid nodules (27–29). The reason that noncancerous conditions uptake 18F-FDG may be due to lesions with a high concentration of inflammatory cells, including neutrophils and activated macrophages, which increase glucose uptake (30,31). Our case and the case reported by Seo et al (21) exhibited multiple lung nodules of pulmonary amyloidosis with moderate 18F-FDG uptake, and an SUVmax of 1.19 and 1.8, respectively. Our results suggest that positive results of 18F-FDG PET/CT on pulmonary nodules should be interpreted with caution in differentiating pulmonary nodular amyloidosis from malignant lesions.
In conclusion, primary nodular parenchymal pulmonary amyloidosis is a relatively rare condition without classic clinical findings, laboratory tests and radiological results. Despite its rarity, primary nodular parenchymal pulmonary amyloidosis with a pattern of multiple nodules should be cautioned with the differential diagnosis of pulmonary metastases with high 18F-FDG uptake on PET/CT.
References
- 1.Kim HY, Im JG, Song KS, Lee KS, Kim SJ, Kim JS, et al. Localized amyloidosis of the respiratory system: CT features. J Comput Assist Tomogr. 1999;23:627–631. doi: 10.1097/00004728-199907000-00026. [DOI] [PubMed] [Google Scholar]
- 2.Cordier JF, Loire R, Brune J. Amyloidosis of the lower respiratory tract. Clinical and pathologic features in a series of 21 patients. Chest. 1986;90:827–831. doi: 10.1378/chest.90.6.827. [DOI] [PubMed] [Google Scholar]
- 3.Chaudhuri MR, Parker DJ. A solitary amyloid nodule in the lung. Thorax. 1970;25:382–386. doi: 10.1136/thx.25.3.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Moldow RE, Bearman S, Edelman MH. Pulmonary amyloidosis simulating tuberculosis. Am Rev Respir Dis. 1972;105:114–117. doi: 10.1164/arrd.1972.105.1.114. [DOI] [PubMed] [Google Scholar]
- 5.Dyke PC, Demaray MJ, Delavan JW, Rasmussen RA. Pulmonary amyloidoma. Am J Clin Pathol. 1974;61:301–305. doi: 10.1093/ajcp/61.2.301. [DOI] [PubMed] [Google Scholar]
- 6.Brauner GJ, al-Bazzaz F, Mihm MC., Jr Acquired bullous disease of the skin and solitary amyloidoma of the lung. Am J Med. 1974;57:978–986. doi: 10.1016/0002-9343(74)90178-8. [DOI] [PubMed] [Google Scholar]
- 7.Bonfils-Roberts E, Marx AJ, Nealon TF. Primary amyloidosis of the respiratory tract. Ann Thorac Surg. 1975;19:313–318. doi: 10.1016/s0003-4975(10)64023-4. [DOI] [PubMed] [Google Scholar]
- 8.Makinen J, Nickels J, Halttunen PE. Amyloid tumour of the lung. Report of a case and a short review of the literature. Acta Pathol Microbiol Scand A. 1977;85:907–910. [PubMed] [Google Scholar]
- 9.Rubinow A, Celli BR, Cohen AS, Rigden BG, Brody JS. Localized amyloidosis of the lower respiratory tract. Am Rev Respir Dis. 1978;118:603–611. doi: 10.1164/arrd.1978.118.3.603. [DOI] [PubMed] [Google Scholar]
- 10.Desai RA, Mahajan VK, Benjamin S, Van Ordstrand HS, Cordasco EM. Pulmonary amyloidoma and hilar adenopathy. Rare manifestations of primary amyloidosis. Chest. 1979;76:170–173. doi: 10.1378/chest.76.2.170. [DOI] [PubMed] [Google Scholar]
- 11.Schoen FJ, Alexander RW, Hood CI, Dunn LJ. Nodular pulmonary amyloidosis. Description of a case with ultrastructure. Arch Pathol Lab Med. 1980;104:66–69. [PubMed] [Google Scholar]
- 12.Hui AN, Koss MN, Hochholzer L, Wehunt WD. Amyloidosis presenting in the lower respiratory tract. Clinicopathologic, radiologic, immunohistochemical, and histochemical studies on 48 cases. Arch Pathol Lab Med. 1986;110:212–218. [PubMed] [Google Scholar]
- 13.Kamei K, Kusumoto K, Suzuki T. Pulmonary amyloidosis with pulmonary arteriovenous fistula. Chest. 1989;96:1435–1436. doi: 10.1378/chest.96.6.1435. [DOI] [PubMed] [Google Scholar]
- 14.Davis CJ, Butchart EG, Gibbs AR. Nodular pulmonary amyloidosis occurring in association with pulmonary lymphoma. Thorax. 1991;46:217–218. doi: 10.1136/thx.46.3.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Mollers MJ, van Schaik JP, van der Putte SC. Pulmonary amyloidoma. Histologic proof yielded by transthoracic coaxial fine needle biopsy. Chest. 1992;102:1597–1598. doi: 10.1378/chest.102.5.1597. [DOI] [PubMed] [Google Scholar]
- 16.Utz JP, Swensen SJ, Gertz MA. Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993. Ann Intern Med. 1996;124:407–413. doi: 10.7326/0003-4819-124-4-199602150-00004. [DOI] [PubMed] [Google Scholar]
- 17.Khoor A, Myers JL, Tazelaar HD, Kurtin PJ. Amyloid-like pulmonary nodules, including localized light-chain deposition: clinicopathologic analysis of three cases. Am J Clin Pathol. 2004;121:200–204. doi: 10.1309/3GEC-PW24-02F6-V8EK. [DOI] [PubMed] [Google Scholar]
- 18.Biewend ML, Menke DM, Calamia KT. The spectrum of localized amyloidosis: a case series of 20 patients and review of the literature. Amyloid. 2006;13:135–142. doi: 10.1080/13506120600876773. [DOI] [PubMed] [Google Scholar]
- 19.Adžić TN, Stojšić JM, Radosavljević-Ašić GD, Bouros D. Multinodular pulmonary amyloidosis in primary Sjögren’s syndrome. Eur J Intern Med. 2008;19:e97–e98. doi: 10.1016/j.ejim.2008.07.029. [DOI] [PubMed] [Google Scholar]
- 20.Yang MC, Blutreich A, Das K. Nodular pulmonary amyloidosis with an unusual protein composition diagnosed by fine-needle aspiration biopsy: a case report. Diagn Cytopathol. 2009;37:286–289. doi: 10.1002/dc.21023. [DOI] [PubMed] [Google Scholar]
- 21.Seo JH, Lee SW, Ahn BC, Lee J. Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT. Lung Cancer. 2010;67:376–379. doi: 10.1016/j.lungcan.2009.11.014. [DOI] [PubMed] [Google Scholar]
- 22.Gillmore JD, Hawkins PN. Amyloidosis and the respiratory tract. Thorax. 1999;54:444–451. doi: 10.1136/thx.54.5.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Pepys MB. Amyloidosis. Annu Rev Med. 2006;57:223–241. doi: 10.1146/annurev.med.57.121304.131243. [DOI] [PubMed] [Google Scholar]
- 24.Wahl RL. Targeting glucose transporters for tumor imaging: ‘sweet’ idea, ‘sour’ result. J Nucl Med. 1996;37:1038–1041. [PubMed] [Google Scholar]
- 25.Duhaylongsod FG, Lowe VJ, Patz EF, Jr, Vaughn AL, Coleman RE, Wolfe WG. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET) J Thorac Cardiovasc Surg. 1995;110:130–139. doi: 10.1016/S0022-5223(05)80018-2. [DOI] [PubMed] [Google Scholar]
- 26.Abouzied MM, Crawford ES, Nabi HA. 18F-FDG imaging: pitfalls and artifacts. J Nucl Med Technol. 2005;33:145–155. [PubMed] [Google Scholar]
- 27.Ollenberger G, Knight S, Tauro A. False-positive FDG positron emission tomography in pulmonary amyloidosis. Clin Nucl Med. 2004;29:657–658. doi: 10.1097/00003072-200410000-00018. [DOI] [PubMed] [Google Scholar]
- 28.Shin L, Katz D, Yung E. Hypermetabolism on F-18 FDG PET of multiple pulmonary nodules res ulting from bronchiolitis obliterans organizing pneumonia. Clin Nucl Med. 2004;29:654–656. doi: 10.1097/00003072-200410000-00017. [DOI] [PubMed] [Google Scholar]
- 29.Hashefi M, Curiel R. Future and upcoming non-neoplastic applications of PET/CT imaging. Ann NY Acad Sci. 2011;1228:167–174. doi: 10.1111/j.1749-6632.2011.06082.x. [DOI] [PubMed] [Google Scholar]
- 30.Brown RS, Leung JY, Fisher S, et al. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between glut-1 expression and FDG uptake. J Nucl Med. 1996;37:1042–1047. [PubMed] [Google Scholar]
- 31.Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med. 1994;35:104–112. [PubMed] [Google Scholar]